CELU — Celularity Inc · rev $26.6M

Celularity Inc (CELU) is a biotechnology company listed on US.

Latest reported CELU revenue for 2025-12-31 was $26.6M. Net income was -$91.7M. Revenue was down 51.0% from 2024-12-31 to 2025-12-31. CELU currently screens at market cap $25.2M.

Use this CELU page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CELU quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CELU SEC filings page. Lician reads the product cache first so this HTML stays unique to Celularity Inc even when a live quote feed is slow.

Celularity Inc latest statements (FY2025)

Latest cached year on this hub. Full CELU income, balance, and cash tables.

  • Revenue$26.6M
  • Net Income-$91.7M
  • Total Assets$107.3M
  • Total Debt$33.8M
  • Free Cash Flow$0

CELU recent filings